A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers

Pim B. Olthof, Mamoru Miyasaka, Bas Groot Koerkamp, Jimme K. Wiggers, William R. Jarnagin, Takehiro Noji, Satoshi Hirano, Thomas M. van Gulik

Research output: Contribution to journalArticleAcademicpeer-review

44 Citations (Scopus)

Abstract

Background: Perihilar cholangiocarcinoma (PHC) often requires extensive surgery which is associated with substantial morbidity and mortality. This study aimed to compare an Eastern and Western PHC cohort in terms of patient characteristics, treatment strategies and outcomes including a propensity score matched analysis. Methods: All consecutive patients who underwent combined biliary and liver resection for PHC between 2005 and 2016 at two Western and one Eastern center were included. The overall perioperative and long-term outcomes of the cohorts were compared and a propensity score matched analysis was performed to compare perioperative outcomes. Results: A total of 210 Western patients were compared to 164 Eastern patients. Western patients had inferior survival compared to the East (hazard-ratio 1.72 (1-23-2.40) P < 0.001) corrected for age, ASA score, tumor stage and margin status. After propensity score matching, liver failure rate, morbidity, and mortality were similar. There was more biliary leakage (38% versus 13%, p = 0.015) in the West. Conclusion: There were major differences in patient characteristics, treatment strategies, perioperative outcomes and survival between Eastern and Western PHC cohorts. Future studies should focus whether these findings are due to the differences in the treatment or the disease itself.
Original languageEnglish
Pages (from-to)345-351
JournalHPB: The official journal of the International Hepato Pancreato Biliary Association
Volume21
Issue number3
Early online date2018
DOIs
Publication statusPublished - 2019

Cite this